Show simple item record

dc.contributor.authorMartins, José Paulo
dc.contributor.authorSantos, Jorge Miguel
dc.contributor.authorde Almeida, Joana Marto
dc.contributor.authorFilipe, Mariana Alves
dc.contributor.authorde Almeida, Mariana Vargas Teixeira
dc.contributor.authorAlmeida, Sílvia Cristina Paiva
dc.contributor.authorÁgua-Doce, Ana
dc.contributor.authorVarela, Alexandre
dc.contributor.authorGilljam, Mari
dc.contributor.authorStellan, Birgitta
dc.contributor.authorPohl, Susanne
dc.contributor.authorDittmar, Kurt
dc.contributor.authorLindenmaier, Werner
dc.contributor.authorAlici, Evren
dc.contributor.authorGraça, Luís
dc.contributor.authorCruz, Pedro Estilita
dc.contributor.authorCruz, Helder Joaquim
dc.contributor.authorBárcia, Rita Nogueira
dc.date.accessioned2015-10-15T08:26:57Zen
dc.date.available2015-10-15T08:26:57Zen
dc.date.issued2014en
dc.identifier.citationTowards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data. 2014, 5 (1):9 Stem Cell Res Theren
dc.identifier.issn1757-6512en
dc.identifier.pmid24438697en
dc.identifier.doi10.1186/scrt398en
dc.identifier.urihttp://hdl.handle.net/10033/579735en
dc.description.abstractStandardization of mesenchymal stromal cells (MSCs) manufacturing is urgently needed to enable translational activities and ultimately facilitate comparison of clinical trial results. In this work we describe the adaptation of a proprietary method for isolation of a specific umbilical cord tissue-derived population of MSCs, herein designated by its registered trademark as UCX®, towards the production of an advanced therapy medicinal product (ATMP).
dc.language.isoenen
dc.subject.meshCells, Cultureden
dc.subject.meshCryopreservationen
dc.subject.meshHumansen
dc.subject.meshMesenchymal Stem Cell Transplantationen
dc.subject.meshMesenchymal Stromal Cellsen
dc.subject.meshQuality Controlen
dc.subject.meshStem Cell Researchen
dc.subject.meshTissue and Organ Harvestingen
dc.subject.meshUmbilical Corden
dc.titleTowards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.en
dc.typeArticleen
dc.identifier.journalStem cell research & therapyen
refterms.dateFOA2018-06-13T14:17:14Z
html.description.abstractStandardization of mesenchymal stromal cells (MSCs) manufacturing is urgently needed to enable translational activities and ultimately facilitate comparison of clinical trial results. In this work we describe the adaptation of a proprietary method for isolation of a specific umbilical cord tissue-derived population of MSCs, herein designated by its registered trademark as UCX®, towards the production of an advanced therapy medicinal product (ATMP).


Files in this item

Thumbnail
Name:
martins et al_final.pdf
Size:
2.558Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record